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The unknown modified nucleosidc LJ* has been isolated by enzymatic and HPLC protocols from tRNALe” (U*AA) rcxently discovered in brewer’s 
ycnst. The pure U* nuclcoside has ken characterized by electron impact mass spectroscopy, and comparison of its chromntogr~phic and 
W-absorption properties with those of appropriate synthetic ompounds. The structure of U* was established as 2’-O-methyl-5-carbamoylmcth- 
yluridine (ncm5LJm). The yeast tRNAL”” (U*AA) is the only tRNA so far sequenced which has been shown to contain ncm%m. The location of 
such a modified uridinc at the first position of the anticodon restricts the decoding property to A of IIIC lcucine UUA codon. 
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1. INTRODUCTION 
Among the very few brewer’s yeast tRNAs whose 
primary structures are unknown, we recently discov- 
ered, purified, and sequenced a new tRNAL’” (U*AA) 
[l]. It is the third cytoplasmic tRNAL”” isolated from 
.Succ/za~omyc~s erevisiae so far; the others which are 
known are tRNALU (m%AA) [2,3], and tRNAL’” 
(UAG) [4]. The major characteristic of this new 
tRNALe” (U*AA) is the presence of an unknown nucle- 
oside in the wobble position of the anticodon. Prelimi- 
nary studies [l], including two-dimensional thin-layer 
chromatography and UV-absorption spectrum of non- 
radioactive material, showed that this unknown nucleo- 
side is a uridine derivative, designated U*. 
Using the combined means of high performance liq- 
uid chromatograplly (I-IPLC), real-time UV-absorption 
spectroscopy, and mass spectrometric measurements, 
we report here on the isolation of this U* nucleoside 
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from purifed yeast tRNAL”” (U*AA), and on its identi- 
fication as 2’-O-methyl-S-carbamoylmethyluridine 
(ncm’um). The coding properties of this modified nu- 
cleoside are also reported. 
2. EXPERIMENTAL 
2.1. Pur&xrion of yeast tRNALY(U*AA) 
The yeast tRNAL”” (U*AA) was purilied by means of counter- 
current distribution of total brewer’s yeast tRNA (lochringer, 
Mannheim, Germany). followed by polyncrylamide gel electrophorc- 
sis. as previously described [5.6]. 
The U* nucleoside was isohttd from purified yeast tRNAhu 
(U*AA) using the analytical proccdurc previously described for the 
isolation of other unknown nuclcosides [7,8]. This procedure can be 
summarized as follows: 
(i) nuclcase PI (Bocbringcr, Mannhcim, Germany) digestion, followed 
by bacterial alkaline phosphntase (BAP) (Sigma, St. Louis, USA) 
treatment. of tRNAbu (U*AA) sample @bout 50 A, U in 200 ~1 
water); 
(ii) isolation by HPLC of a U*pA dinucleotide resistant lo nuclcase 
Pi action; _ 
(iii) combined hydrolysis by snskc venom ph~xphodicnerase (SV- 
PDE) (Sigma, St. Louis, USA) and BAP of the U*pA dincclcotidc 
sample, leading to the liberation of fret U* and adcnosine (A) 
mononucleosides; 
(iv) isolation and dcsdlling of U* mononucleosidc by HPLC. 
Analysis, isolation, and desalting of the ribonuclcosidcs by HPLC 
were performed using the cxperimenmi condiliuus previousijj de- 
scribed [7.9-l I]. 
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The conversion of U* nucleoside (approx. 2blg) to the trimethylsilyl 
(TMS) derivative. and the electron impact mass spectroscopy (EL-MS) 
ol’silylated U* by dirLx:t-probe introduction, were carried out as pre- 
viously reported [7]. 
2.4. Acidic trcumenI of U* nucieoside 
1 pg of the pure unknown compound was incubaled in 100 ~1 
1.8 N HCI nt 60% for I II, and further analyzed by HPLC. The 
resulting product was isolated, converted to :hc trimcthylsilyl dcrivs- 
tivc, and characterized by mass spectrometry. 
3. RESULTS 
3.1, Isolation of pure U* rrucleosidc 
Fig. I shows the HPLC nucleoside analysis of 
S. cerevisiae tRNALc” (U*AA) after exhaustive nuclease 
Pl digestion followed by BAP hydrolysis. The peak that 
eluted at 48 min retention time was designated as a 
nuclease Pl-resistant unknown compound, Nd8, and 
collected. As shown in Fig. 2a, the unknown N,,B yielded 
two mononuclcosides upon SV-PDE plus BAF treat- 
ments. 
One of these mononucleosides was easily identified as 
unmodified adenosine (A) by comparison of its HPLC 
retention time and US-absorption spectrum with those 
of authentic adenosine. 
The second nucleoside was collected, desalted, and 
concentrated. This compound exhibited a UV-absorp- 
tion spectrum (Fig. 2b) which was very similar to that 
OF 5-carbamoylmethyluridinc ( cmsU), previously iden- 
tified in different eukaryotic tRNAs”‘” [12,13]. How- 
ever, its HPLC retention time (25.7 min) did not corre- 
spond either to ncmsU nucleoside, or to any of the 
modified uridines so far characterized. From these re- 
sults and because of the behavior of U* in two-dimen- 
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Fig. 1, HPLC chromatogram of nucleosidcs resulting from nuclcase 
PI plus bacterial alkaline phosphntnsc dig&on of the tbird cytoplas- 
mic tRNAL”“, i.e. tRNAL”” (U*AA). isolated from brewer’s yeast [I]. 
The peak. N,8, corresponds to un unknown dinucleolide U*pA eluted 
al 48 min retention time. 
sional thin-layer chromatography (results not shown), 
it was supposed that the structure of the unknown U* 
could be close to that of ncm%J. Further investigations 
on mass spectrometry of U* and its derivative upon 
acidic treatment confirmed this hypothesis. 
3.2. Temarive characterization of Urn as ttctdUtn by 
mass specrronzetry 
The chemical structure of U* as 2’-O-methyl-S-car- 
bamoylmethyluridine was postulated from the EI-MS 
fragmentation of U* as a TMS derivative. As reported 
previously For TMS derivatization of modified uridines 
[I419 and especially of ncmsU from eukaryotic 
B U*pA 
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Fig. 2. (a) HPLC chromatogram of mononucleosidcs resulting from incomplete snake venom phospbodicsterase plus bacterial alkaline phasphatase 
hydrolysis of the unknown NdtI dinucleotidc, i.e. U*pA, isolated by HPLC from brervcr’s yeast !r‘NA&” (U*AA). The peak designated as U* wus 
collected, dcsnllcd, and concentrated. (b) Renl-time UV-absorption spectrum of the unknown U* nucleosidc from brewer’s yeast tRNALP” (U*AA), 
as compared to that of authentic %arbamoylmethyluridine (ncmsU) isolated from yeast, or chicken liver, or beef liver tRNA”‘” [12]. 
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tRNA”‘“‘s [ 131, the trimethylsilylation of U* from yeast 
tRNAL”” (U*AA) led to two TMS derivatives. From the 
resulting EI-mass spectrum presented in Fig. 3a, several 
ion series have been summarized in Table I. 
The two major series of fragment ions shown in Table 
I result from fragmentation of the molecular ion of the 
(TMS)4 derivative (m/z 603) designated Mz, and of the 
molecular ion of the (TMS)3 derivative (W/Z 531) desig- 
nated Mi. These tjvo molecular ions, M,” and M& are 
in agreement with a 2’-O-methyl-S-carbamoylmethylu- 
ridine structure for the silylated t_J* nucleoside. Two 
significant fragment ions at ntlz 488 (M, - 115) and m/z 
416 (Mb - 115) affirm the presence of a S-carba- 
moylmethyl group on U* nucleoside, since they result, 
as in the fragmentation pathway previously described 
for the EI-MS of silylated ncm’U [12,13], from the re- 
moval of the fragment CO-NSi(CH3)s from each molec- 
ular ion. 
Another essential structure information for U* struc- 
ture was gained from the ions at m/z 291,259,2OI, 187 
and 159, which are characteristic of the fragmentation 
af a ribose moiety carrying a methoxy group on the 
carbon 2’ [15]. The presence of the fragment ion M, 
-CH30H at nalz 57 1 and the concomitant absence of the 
fragment M, -(CH&SiOH at m/z 513 arc also charac- 
teristic of the fragmentation pathway observed in the 
ELmass spectra of the modified 2’-O-methyluridines as 
TMS derivatives [14]. Numerous other ion peaks at m/z 
516, 386, 353, 341, 313 and 270, confu-m the ncm5Um 
structure for U* because they contain the intact base 
part, B, or Bb, plus portions of the 2’-O-methylribose 
moiety. 
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Fig. 3. Electron impact (EI) mass spectrum of the trimethylsilyl (TVS) derivative of U* nuclcosidc isoiated from brcwcr’s yeast RNAh” (U*AA) 
(n, upper panel), as compared to that of the (TMS) derivative of the ccmpound resulting from acidic treatment of U* (b. lower panel). The structure 
for this new modilicd uridine ‘U* as 2’-O-methyl-j-carbamoyimc~hyluridinc (ncnt%Jrn) ttras dtitc~d from the ~$6 frngmcnt ion series &scr%%! 
in Table I, resulting from fragmentation of two molecular ions rnlr 603 [Ma), and rnlz 531 (Mb) for the (TMS), and (TMS), derivatives of U*, 
respectively. The El-mass spectrum of the PMS) product resulting from acidic treatment of U* (b, lower panel) contirmed this slruclurc by leading 
to Fragmentation pathways in agreement with a 2’-O-me~byl-5~cnrboxyn~thy~uridirlc (cm5Um) structure. 
383 
Volume 314, number 3 FEBS LETTERS December 1992 
Confirmation of the 5-carbamoylmcthyl side chain 
on U* was gained from HPLC and EI-MS analysis of 
the compound resulting from acidic treatment of U*. 
When chromatographed by HPLC, the only resulting 
product of such a treatment of LJ* eluted at 16.3 min 
retention time, i.e. about 9.5 min earlier than U* (results 
not shown). This compound was collected, desalted, 
and submitted to EI-MS analysis as a TMS derivative. 
In the resulting EI-mass spectrum presented in Fig. 3b, 
all ion peaks with high relative intensities are in agree- 
ment with the expected fragmentation pathways of two 
TMS derivatives of a 2’-O-methyl-S-carboxymethylu- 
ridine (cm%Jm) structure: (i) molecular ion M: at ~?z/z 
604 of the (TMS).+ derivative, and molecular ion Mi at 
ntlz 532 of the (TMS)3 derivative; (ii) molecular ion 
series at m/z 589 (M, -CM& 572 (M, -CH,OH), 517 
(M,-CH,); (iii) base ion peaks containing the intact 
base part B, of the (TMS), derivative plus portions of 
the sugar moiety, e.g. fragment ions at m/z 501 (B, 
-t-188), 445 (B, I-132), 415 (B, +102), 387 (B, +74), 371 
(B,, + 58), 354 (B, +41), 315 (B, +2); (iv) sugar ion series 
at tr~/z 290 (S -l), 2Cl (S -9O), 187 (S -104), resulting 
from the cleavages of the 2’“O-methylribose moiety. 
Thus, the side chain linked to the carbon 5 of U* nucle- 
aside is really a carbamoylmethyl group, since acidic 
treatment of U* hydrolyses the amide function of this 
CHz-CO-NH7 group carried by ncm5Um into CH?- 
COOH acid group carried by the resulting cmsUm. 
Table I 
Fragment-ion series from electron impact mass spectroscopy of U* 
nuclrosidc (Le. ncm5Um) isolated from the yeast leucinc tliNA 
(U*AA), as trimcthylsilyl [(TMS),, and (TMS),] derivatives 
Mass From molecular ion (TMS), From molecular ion (TMS), 
(WI:) 
IO&l’ Composition Ion’ Composition 
603 M, Molecular ion - - 
(TMS)., 
588 M, -15 M, -CH3 - - 
571 M, -32 M, -CH,OH - 
488 M, -115 ha,-CON(TMSj - - 
531 - Mb Molecular ion 
(TMS), 
416 M, - 187 M, -CH,OH Mb -I 15 Mb -CON(TMS) 
-C,H,CONH(TMS) 
516 B,,+204 B,+CIH,02(TMS)1 Mb -15 M, -CH3 
3% s,,+74 B,+H+(TMS) - - 
353 B,I-41 B,, + CzHO - 
341 B,+29 B,+CHO - 
313 9,+1 B,, + H - 
270 - - Bb-k30 - B,,+CH20 
291 s Sugar moiety S Sugar moiety 
259 s -32 S -CH,OH S -32 S -CH30H 
201 s -90 S -(TMS)OH s -90 Y -(TMS)OH 
187 S - 104 S -H -CHzO(TMS) S - 104 S-H -CH&( I‘MS) 
I59 s -132 C3H,02(TMS)2 S - 132 C,HS02(TMS)2 
103 - CH20(TMS) CH,O(TMS) 
B,, base moiety of (TM!& tcrivative; B,,, base mocity of (TMS), 
dcdvative. 
384, 
3.3. &$nirive cortJinnaiion of the chemical swuccure for 
U* as ncm’Um 
Recently, the authentic ncm’Um pucleoside was 
chemically synthesized, and its structure was character- 
ized and rigorously established by protonated nuclear 
magnetic resonance (‘H NMR) and EI-MS of underiva- 
tized compound [16]. HPLC under standard chrornato- 
graphic conditions and real-time UV-spectrornetric 
measurements were applied on this reference ncm’Um 
nucleoside. HPLC retention time and L”V-absorption 
spectrum of the standard compound were strongly iden- 
tical to those of U* nucleoside isolated from yeast 
tRNALe” (U*AA). In addition, the resulting products 
upon acidic treatments of U* and reference ncm5Um 
exhibited identical chromatographic and UV-spectro- 
metric properties. 
These results definitively confirmed the chemical 
structure of U* as 2’-U-methyl-S-carbamoymethyluri- 
dine (ncm’Um) (Fig. 4a), as well as the 2’.O-methyl-S- 
carboxymethyl-uridine (cm’Um) structure for the nu- 
cleoside resulting from acidic treatment of U* (Fig. 4b). 
3.4. r~r$Unt decodes only A in protein synrhesis 
In vitro protein synthesis experiments (not shown) of 
a-globin mRNA (containing 18 CUN and 2 UUG lcuc- 
ine codons), j?-globin mRNA (containing 21 CUN leuc- 
ine codons), and Brom mosaic virus (BMV) coat pro- 
tein RNA 4 (containing all 6 leucine codons), led to 
radioactive protein only of the latter when [“‘Clleucyl 
tRNAL’” (ncm%JmAA) was used. But with 
[“Clleucyl tRNALcu (UAG), we obtained all three radi- 
oactive proteins, and with [‘“C]ler~yl tRNA”” 
(m%AA), we obtained only radioactive a-globin and 
BMV coat protein, meaning that the modifications of 
the pyrimidine nucleotide located at the wobble position 
of PyAA leucine anticodons restrict the decoding prop- 
erties to either A, when it is ncm%m, or G, when it is 
mSC. 
(‘) OH 0-G OH 
CH2-CO-NH2 CHp200H 
0 
HOCH2 o 
5-Y 
Hd -0.CH, 
Fig. 4. Structures of (a) 2’-O-methyl-5carbntnoylmcthy1uridioe 
(ncm’um), locakd at the first position or the anticodon in the third 
cytoplasmic tRNAL”” (ncm%lmAA) isolated from brewer’s yeast, and 
(b) 2’-0-methyl-5-carboxymethyluridinc (cm5Um), obtnincd by acidic 
Lrcalmcnt of ncm’Um. 
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4. DISCUSSION 
Among all the tRNAs so far sequenced, the yeast 
tRNAL”” (U*AA) is the first tRNA which has been 
shown to contain 2’.U-methyl-S-carbamoylmcthyfuri- 
dine (ncm’Um). In previcus studies [17], this modified 
nuclcoside was tentatively characterized in crude un- 
fractionated yeast tRNAs by its chromatographic, elec- 
trophoretic, and UV-absorption spectrometric proper- 
ties as compared with those of semi-synthetic methyl 
ester and amide derivatives of 2’-O-methyl&carbox- 
ymethyluridine (cm%Jm). At this time, the author pre- 
dicted that the postulated ncm%Jm should be found in 
a leucine, isoleucine, or valine isoacceptor tRNA. 
Our previous [l] and present studies e?e complemen- 
tary to these results and hypothesis ince; (1) they rigor- 
ously establish the chemical structure of ncm”Um, and 
(ii) they clearly defne the yeast tRNA carrying this 
modified nucleoside as the tRNALc” recently isolated 
from brewer’s yeast. This tRNA is the only one in yeast 
carrying ncm%m, as checked throughout all fractions 
of a counter-current distribution of total yeast tRNAs 
(not shown). 
Our in vitro protein synthesis results allow a better 
clarification of the respective functions of the three 
known yeast tRNAs “” in the translation of the 6 lcucinc 
codons in yeast. Indeed, the tRNAL’” (ncm’UmAA) 
decodes the codon UUA (where ncmSUm base pairs 
with A), the tRNALeU (m’CAA) decodes the codon 
UUG (where m5C base pairs with G), whereas the 
tRNALc” (UAG) decodes the 4 CUN leucine codons 
according to the ‘wobble’ hypothesis [18], and despite 
the in vitro results by others [19’J who found that this 
tRNA could recognize all G leucine codons (CUN, 
UUA and UUG), but in the absence of the two other 
tRNAsb”. 
In addition, recent studies [20], have shown that the 
modifications of U in position 34 of tRNAs contribute 
to the correct and efficient codon recognition through 
t.he regulation of the conformational ‘rigidity-flcxibil- 
ity’ of the first letter of the anticodon. Therefore, in the 
case of ncm’l_Jm in yeast tRNALc” (U*AA), the collabo- 
rative effects of both 2’-U-methylation and S-substitu- 
tion, could bring the required rigidity to this nucleotide 
to allow the exclusive recognition of A in the third 
position of the codon. 
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